Table 4.
Comparison of the mean ± S.E of the haematological parameters after 20 days of HAART administration with the control group.
| Parameter | Group A 0 mg/Kg |
Group B 3 mg/Kg |
Group C 6 mg/Kg |
Group D 12 mg/Kg |
Group E 24 mg/Kg |
|---|---|---|---|---|---|
| RBC (×1012/L) | 7.80 ± 1.20 | 8.42 ± 0.08 | 7.86 ± 0.31 | 6.76 ± 0.93 | 7.40 ± 0.02 |
| HB (g/dL) | 13.80 ± 1.60 | 15.60 ± 0.50 | 13.70 ± 0.40 | 12.71 ± 1.30 | 13.15 ± 0.05 |
| PCV (L/L) | 53.50 ± 6.50 | 56.95 ± 0.95 | 51.00 ± 1.00 | 47.75 ± 5.75 | 50.60 ± 1.40 |
| MCHC (g/dL) | 26.05 ± 0.05 | 27.55 ± 1.45 | 26.70 ± 0.40 | 26.80 ± 0.60 | 26.15 ± 0.85 |
| MCV (fL) | 70.55 ± 1.65 | 67.60 ± 0.50 | 65.30 ± 1.70 | 70.70 ± 0.70 | 68.70 ± 1.70 |
| MCH (pg) | 18.25 ± 0.55 | 18.55 ± 0.75 | 17.45 ± 0.15 | 18.90 ± 0.70 | 17.80 ± 0.10 |
| RETICS (%) | 1.35 ± 0.15 | 1.20 ± 0.20 | 0.95 ± 0.05 | 1.50 ± 0.05 | 1.15 ± 0.25 |
| PLAT (×109/L) | 534.00 ± 95.50 | 516.00 ± 37.00 | 787.50 ± 1.50 | 941.00 ± 320.00 | 958.00 ± 166.00 |
| WBC (×109/L) | 7.20 ± 0.60 | 7.95 ± 1.55 | 7.65 ± 2.05 | 6.95 ± 1.65 | 11.90 ± 2.40 |
| NEUT (%) | 28.00 ± 14.00 | 24.00 ± 4.00 | 25.50 ± 2.50 | 17.50 ± 4.50 | 7.50 ± 0.50 |
| LYMPH (%) | 72.00 ± 14.00 | 76.00 ± 4.00 | 74.5 ± 2.50 | 81.00 ± 5.00 | 92.50 ± 0.50 |
| EOS (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| MONO (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 1.50 ± 0.50 | 0.00 ± 0.00 |
| BAS (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
RBC: red blood cell, HB: haemoglobin concentration, PCV: packed cell volume, MCHC: mean cell haemoglobin concentration, MCV: mean cell volume, MCH: mean cell haemoglobin, RETICS: reticulocytes, PLAT: platelets, WBC: white blood cell, NEUT: neutrophils, LYMPH: lymphocytes, EOS: eosinophils, BAS: basophils.